| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |